- Free from Publisher A Haupt, C Kausch, D Dahl, O Bachmann, M … - Diabetes care, 2002 - Am Diabetes Assoc RESULTS—Glimepiride had no significant effect on basal glycogen synthesis; in
contrast, glimepiride caused a dose-dependent increase of insulin-stimulated
glycogen synthesis, with a maximal effect of 39.97 ± 8.4% (mean ± SEM, n ... Cited by 12 - Related articles - BL Direct - All 5 versions
[CITATION] Glimepiride/Glyburide Research Group, 1996. Clinical evaluation of Glimepiride versus …
K Inukai, M Watanabe, Y Nakashima, T Sawa, … - Diabetes research and clinical practice, 2005 - Elsevier We investigated the efficacy of glimepiride, a third-generation sulfonylurea
(SU), in Japanese type 2 diabetic patients in whom glycemic control had been
inadequate with a conventional SU, gliclazide or glibenclamide. A total of ... Cited by 8 - Related articles - All 10 versions
[CITATION] Differential interaction of glimepiride and glibenclamide with the ß-cell Sulphonylurea …
- ►nih.gov [PDF] G Müller - Molecular Medicine, 2000 - pubmedcentral.nih.gov The hypoglycemic sulfonylurea drugs cause reduc- tion of blood glucose
predominantly via stimulation of insulin release from pancreatic cells. In
addition, during long-term treatment, an insulin-independent blood glucose- ... Cited by 41 - Related articles - BL Direct - All 4 versions
[CITATION] The 3rd Gen. Sulphonylurea with Specific properties (Cardioprotective, Insulin Sparing …
R Kawamori, T Morishima, M Kubota, M … - Diabetes research and clinical practice, 1995 - cat.inist.fr Although the metabolic derangement in the subjects with well-established NIDDM
is characterized by both insulin resistance and diminished insulin secretion,
the impaired sensitivity to insulin in the target tissues is assumed to ... Cited by 11 - Related articles - All 4 versions
K Inukai, M Watanabe, Y Nakashima, N Takata … - Biochemical and Biophysical Research …, 2005 - Elsevier Glimepiride, a third-generation sulfonylurea (SU), exerts its effects mainly by
stimulating insulin secretion but has also been shown to have pleiotropic
effects. Recent clinical studies showed glimepiride to enhance insulin ... Cited by 15 - Related articles - All 3 versions
M Badian, A Korn, KH Lehr, V Malerczyk, W … - Drug metabolism and drug interactions, 1996 - ncbi.nlm.nih.gov Glimepiride is a new sulphonylurea which is eliminated by the formation of a
hydroxy-metabolite (hydroxy-gli) and a carboxymetabolite (carboxy-gli). Animal
studies have shown hydroxy-gli to exhibit some hypoglycaemic effects while ... Cited by 19 - Related articles - BL Direct
